Earnings Call · Q2 FY2025·2025-08-07

Q2 25EPS +12.48%·Rev n/aQ1 25EPS -3.47%·Rev n/aQ4 24EPS +5.00%·Rev n/aQ3 24EPS -19.73%·Rev n/a⚠ consensus missing

ELI LILLY & Co LLY

Ilya Yuffa — Executive Vice President, President of Lilly Diabetes and Obesity

David A. Ricks — Chairman and Chief Executive Officer

Lucas E. Montarce — Senior Vice President and Chief Financial Officer

Daniel M. Skovronsky — Chief Scientific and Medical Officer

Michael Czapar — Senior Vice President of Investor Relations

−14.1%1d on move date−14.1% vs SPY3d−14.9%5d−11.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LLY calls or request research access.

More LLY calls Browse calls Request research access